SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-013983
Filing Date
2024-05-21
Accepted
2024-05-21 17:05:25
Documents
1
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 form4-05212024_050508.html 4  
1 form4-05212024_050508.xml 4 7394
  Complete submission text file 0001415889-24-013983.txt   9083
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 83 ANGLESSA ROAD BALLSBRIDGE, DUBLIN L2 D04H27
Business Address
Haigh Adrian (Reporting) CIK: 0001717425 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 24970536